ROPES WEALTH ADVISORS LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 164 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$278,000
-11.7%
2,3500.0%0.05%
-2.0%
Q3 2021$315,000
-17.1%
2,3500.0%0.05%
-16.7%
Q2 2021$380,000
+196.9%
2,3500.0%0.06%
+200.0%
Q4 2020$128,000
+1728.6%
2,350
+571.4%
0.02%
+1900.0%
Q3 2020$7,0000.0%3500.0%0.00%0.0%
Q2 2020$7,000
+75.0%
3500.0%0.00%0.0%
Q1 2020$4,000
-20.0%
3500.0%0.00%0.0%
Q4 2019$5,0000.0%3500.0%0.00%0.0%
Q3 2019$5,000
-77.3%
350
-74.1%
0.00%
-80.0%
Q2 2019$22,000
+266.7%
1,350
+285.7%
0.01%
+150.0%
Q1 2019$6,0003500.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders